The biotechnology company SpliceBio, a member of Catalonia.Health, has been awarded Biotech of the Year at the 2025 European Lifestars Awards, and has been selected as a finalist in several leading international awards in the life sciences sector. These nominations demonstrate SpliceBio’s growing presence in the international biotech ecosystem and its advancement in the development of gene therapy technologies.

SpliceBio has been awarded in the been 2025 European Lifestars Awards in Biotech of the Year. Also they have been shortlisted for the 2025 European Lifestars Awards in Best Series B Raise. The Lifestars Awards acknowledge outstanding achievements across the global biotech and investment landscape, and SpliceBio’s nominations reflect the company’s continued scientific and corporate progress.

Additionally, the company has been named as finalist in the 2025 Scrip Awards under the category Business Development Team of the Year. The Scrip Awards are recognized globally for highlighting excellence and innovation in biopharmaceutical research, development, and business strategy.